To support large scale vaccination efforts, Yale University is collaborating with Yale New Haven Health System (YNHHS) to expand vaccination availability to the general public.
“I am grateful that members of the Yale and New Haven communities were able to...
Patients with Type 2 diabetes who were treated with the newer generation of insulin analog drugs did not have substantially better outcomes than those treated with less costly human insulin, according to a study by Yale School of Medicine researchers and...
In a new study of languages spoken in 43 different populations worldwide, Yale School of Medicine researchers and their colleagues identified variants of a dyslexia gene that correlate with consonant use, establishing a role for genetics in language...
Impoverished female farm workers infected with intestinal parasites known as hookworms saw significant improvements in physical fitness when they were treated with a low-cost deworming drug. The benefits were seen even in those with low level infections,...
More than one-third of adults in China have high blood pressure — often dubbed the “silent killer” for its lack of symptoms — but only about one in 20 have the condition under control. These findings are published Oct. 25 in the Lancet’s special issue on...
By the time multiple sclerosis (MS) is diagnosed in children, it may be difficult to prevent the disabilities and relapses that come with the disease. In a new Yale School of Medicine study, researchers examined MRI brain scans to identify children at...
Yale School of Medicine metabolism researcher Sabrina Diano has been selected to receive the Helmholtz Diabetes Award during the 6th annual Helmholtz Conference Sept. 26-28, 2018 in Munich, Germany. Diano is the first woman to receive the award, which...